Guidance document: management priorities in salicylate toxicity.

Article Details

Citation

Authors unspecified

Guidance document: management priorities in salicylate toxicity.

J Med Toxicol. 2015 Mar;11(1):149-52. doi: 10.1007/s13181-013-0362-3.

PubMed ID
25715929 [ View in PubMed
]
Abstract

Not Available

DrugBank Data that Cites this Article

Drugs
Drug Interactions
DrugsInteraction
Bismuth subsalicylate
Aminosalicylic acid
The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Bismuth subsalicylate.
Bismuth subsalicylate
Salicylic acid
The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Salicylic acid is combined with Bismuth subsalicylate.
Bismuth subsalicylate
Olsalazine
The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Bismuth subsalicylate.
Bismuth subsalicylate
Mesalazine
The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Mesalazine is combined with Bismuth subsalicylate.
Choline salicylate
Aminosalicylic acid
The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Aminosalicylic acid is combined with Choline salicylate.